391 related articles for article (PubMed ID: 29594778)
1. Protein-Protein Docking in Drug Design and Discovery.
Kaczor AA; Bartuzi D; Stępniewski TM; Matosiuk D; Selent J
Methods Mol Biol; 2018; 1762():285-305. PubMed ID: 29594778
[TBL] [Abstract][Full Text] [Related]
2. Computational Methods Used in Hit-to-Lead and Lead Optimization Stages of Structure-Based Drug Discovery.
Heifetz A; Southey M; Morao I; Townsend-Nicholson A; Bodkin MJ
Methods Mol Biol; 2018; 1705():375-394. PubMed ID: 29188574
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Ligand Binding to GPCRs Through Computational Methods.
Vasile S; Esguerra M; Jespers W; Oliveira A; Sallander J; Åqvist J; Gutiérrez-de-Terán H
Methods Mol Biol; 2018; 1705():23-44. PubMed ID: 29188557
[TBL] [Abstract][Full Text] [Related]
4. Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands.
Bermudez M; Wolber G
Bioorg Med Chem; 2015 Jul; 23(14):3907-12. PubMed ID: 25828056
[TBL] [Abstract][Full Text] [Related]
5. Computational methods for studying G protein-coupled receptors (GPCRs).
Kaczor AA; Rutkowska E; Bartuzi D; Targowska-Duda KM; Matosiuk D; Selent J
Methods Cell Biol; 2016; 132():359-99. PubMed ID: 26928552
[TBL] [Abstract][Full Text] [Related]
6. Computational studies of G protein-coupled receptor complexes: Structure and dynamics.
Sensoy O; Almeida JG; Shabbir J; Moreira IS; Morra G
Methods Cell Biol; 2017; 142():205-245. PubMed ID: 28964337
[TBL] [Abstract][Full Text] [Related]
7. Structure-based molecular modeling approaches to GPCR oligomerization.
Kaczor AA; Selent J; Poso A
Methods Cell Biol; 2013; 117():91-104. PubMed ID: 24143973
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in computational studies of GPCR-G protein interactions.
Wang J; Miao Y
Adv Protein Chem Struct Biol; 2019; 116():397-419. PubMed ID: 31036298
[TBL] [Abstract][Full Text] [Related]
9. Hot-spot analysis for drug discovery targeting protein-protein interactions.
Rosell M; Fernández-Recio J
Expert Opin Drug Discov; 2018 Apr; 13(4):327-338. PubMed ID: 29376444
[TBL] [Abstract][Full Text] [Related]
10. Modeling Binding Affinity of Pathological Mutations for Computational Protein Design.
Romero-Durana M; Pallara C; Glaser F; Fernández-Recio J
Methods Mol Biol; 2017; 1529():139-159. PubMed ID: 27914049
[TBL] [Abstract][Full Text] [Related]
11. Modeling and Deorphanization of Orphan GPCRs.
Diaz C; Angelloz-Nicoud P; Pihan E
Methods Mol Biol; 2018; 1705():413-429. PubMed ID: 29188576
[TBL] [Abstract][Full Text] [Related]
12. Assessing GPCR homology models constructed from templates of various transmembrane sequence identities: Binding mode prediction and docking enrichment.
Loo JSE; Emtage AL; Ng KW; Yong ASJ; Doughty SW
J Mol Graph Model; 2018 Mar; 80():38-47. PubMed ID: 29306746
[TBL] [Abstract][Full Text] [Related]
13. Computational approaches for ligand discovery and design in class-A G protein- coupled receptors.
Rodríguez D; Gutiérrez-de-Terán H
Curr Pharm Des; 2013; 19(12):2216-36. PubMed ID: 23016842
[TBL] [Abstract][Full Text] [Related]
14. Advancements in Docking and Molecular Dynamics Simulations Towards Ligand-receptor Interactions and Structure-function Relationships.
Naqvi AAT; Mohammad T; Hasan GM; Hassan MI
Curr Top Med Chem; 2018; 18(20):1755-1768. PubMed ID: 30360721
[TBL] [Abstract][Full Text] [Related]
15. Methodologies for the Examination of Water in GPCRs.
Bortolato A; Tehan BG; Smith RT; Mason JS
Methods Mol Biol; 2018; 1705():207-232. PubMed ID: 29188565
[TBL] [Abstract][Full Text] [Related]
16. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
Bartuzi D; Kaczor AA; Matosiuk D
Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
[TBL] [Abstract][Full Text] [Related]
17. GPCR Homology Model Generation for Lead Optimization.
Tautermann CS
Methods Mol Biol; 2018; 1705():115-131. PubMed ID: 29188560
[TBL] [Abstract][Full Text] [Related]
18. Importance of protein dynamics in the structure-based drug discovery of class A G protein-coupled receptors (GPCRs).
Lee Y; Lazim R; Macalino SJY; Choi S
Curr Opin Struct Biol; 2019 Apr; 55():147-153. PubMed ID: 31102980
[TBL] [Abstract][Full Text] [Related]
19. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
20. Recent Trends and Applications of Molecular Modeling in GPCR⁻Ligand Recognition and Structure-Based Drug Design.
Yuan X; Xu Y
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30036949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
